Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$52,761,377
+$12,712,901 QoQ
Shares Held
345,410
+18.9% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.19950204105267.ToString("F0")%
Shared 0.ToString("F0")%
None 0.8004979589473379.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $30,098,800,763 across 16 Drug Manufacturers - General names. NVS ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
49,765,225 | $5,986,258,914 | |
| 2 | LLY |
ELI LILLY & Co
|
5,897,450 | $5,424,297,586 | |
| 3 | JNJ |
Johnson & Johnson
|
19,177,219 | $4,687,679,411 | |
| 4 | AMGN |
Amgen Inc
|
12,773,386 | $4,494,315,864 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
61,115,373 | $3,706,647,372 | |
| 6 | ABBV |
AbbVie Inc.
|
12,967,398 | $2,820,279,389 | |
| 7 | PFE |
Pfizer Inc
|
51,891,636 | $1,457,117,138 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,181,780 | $1,140,294,678 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,761,377 | 345,410 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $40,048,476 | 290,480 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $33,448,454 | 260,827 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $26,940,455 | 222,630 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $20,691,021 | 185,603 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $16,099,160 | 165,442 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $18,087,585 | 157,256 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $14,719,797 | 138,266 | Shares | Other | 2024-08-12 | |
| 2024-03-31 | $11,666,024 | 120,604 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $14,782,916 | 146,409 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $446,538,858 | 4,383,849 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $445,259,420 | 4,412,441 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $410,539,236 | 4,462,383 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $414,473,734 | 4,568,714 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $344,132,310 | 4,527,461 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $375,672,536 | 4,444,251 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $386,030,940 | 4,399,213 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $367,872,053 | 4,205,694 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $336,644,752 | 4,116,468 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $372,088,672 | 4,078,131 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $343,568,994 | 4,019,291 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $430,917,046 | 4,563,349 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $417,046,246 | 4,795,840 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $441,581,694 | 5,055,893 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $431,098,152 | 5,228,601 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||